Value of the palliative performance scale in the prognostication of advanced cancer patients in a tertiary care setting

Journal of Palliative Medicine

Volumn 16, Issue 8, 2013, Pages 887-893

  Mei, Allyn Hum Yin ^a   Jin, Wilson Low Cong ^a   Hwang, Mervyn Koh Yong ^a   Meng, Yee Choon ^a   Seng, Lee Chung ^a   Yaw, Wu Huei ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; HEMOGLOBIN;

ADVANCED CANCER; AREA UNDER THE CURVE; ARTICLE; BONE CANCER; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL DECISION MAKING; COHORT ANALYSIS; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; HAZARD RATIO; HEAD AND NECK CANCER; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; LEUKOCYTE COUNT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTPATIENT; PALLIATIVE PERFORMANCE SCALE; PALLIATIVE THERAPY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SELF CARE; SKIN CANCER; SURVIVAL TIME; TEACHING HOSPITAL; TERTIARY HEALTH CARE; THROMBOCYTE COUNT; UROGENITAL TRACT CANCER;

AGED; ANALYSIS OF VARIANCE; DEATH CERTIFICATES; FEMALE; HOSPITAL UNITS; HUMANS; INPATIENTS; MALE; NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; ROC CURVE; SINGAPORE; SURVIVAL ANALYSIS; TERMINALLY ILL; TIME FACTORS;

EID: 84880849884     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2012.0556     Document Type: Article

References (19)

1. Christakis NA, Sachs GA: The role of prognosis in clinical decision making. JGIM 1996;11:422-425.
2. Forster LE, Lynn J: The use of physiologic measures and demographic variables to predict longevity among inpatient hospice applicants. Am J Hosp Care 1989;6:31-34.
3. Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME: Survival prediction in terminal cancer patients: A systematic review of the medical literature. Palliat Med 2000;14:363-374.
4. Anderson F, Downing GM, Hill J, Casorso L, Lerch N: Palliative performance scale (PPS): A new tool. J Palliat Care 1996;12: 5-11.
5. Olajide O, Hanson L, Usher BM, Qaqish BF, Schwartz R, Bernard, S: Validation of the Palliative Performance Scae in the acute tertiary care hospital setting. J Palliat Med 2007;10: 111-117.
6. Head B, Ritchie CS, Smoot TM: Prognostication in hospice care: Can the Palliative Performance Scale help? J Palliat Med 2005;8:492-502.
7. Lau F, Downing GM, Lesperance M, Shaw J, Kuziemsky C: Use of the Palliative Performance Scale in end-of-life prognostication. J Palliat Med 2006;:1066-1075.
8. Lau F, Downing GM, Lesperance M, Karlson N, Kuziemsky C, Yang J: Using the Palliative Performance Scale to provide meaningful survival estimates. J Pain Symptom Manage 2009;38:134-144.
9. Downing GM, Lau F, Lesperance M, Karlson N, Shaw J, Kuziemsky C, Bernard S, Hanson L, Olajide L, Head B, Ritchie C, Harrold J, Casarett D: Meta-analysis of survival prediction with Palliative Performance Scale. J Palliat Care 2007;23:245-254.
10. Morita T, Tsunoda J, Inuoe S, Chihara S: Validity of the Palliative Performance Scale from a survival perspective [letter]. J Pain Symptom Manage 1999;18:2.
11. Harrold J, Rickerson E, Carroll JT, McGrath J, Morales K, Kapo J, Casarett D: Is the Palliative Performance Scale a useful predictor of mortality in a heterogeneous hospice population? J Palliat Med 2005;8:503-509.
12. McCarthy EP, Phillips RS, Zhong Z, Drews RE, Lynn J: Dying with cancer : Patients' function, symptoms, and care preferences as death approaches. J Am Geriatr Soc 2000;48(5 Suppl):S110-S121.
13. Teno JM, Weitzen S, Fennell ML, Mor V: Dying trajectory in the last year of life: Does cancer trajectory fit other diseases. J Am Geriatr Soc 2001;4:457-464.
14. Gupta D, Lis CG: Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutrition J 2010;9:69.
15. Seve P, Ray-Coquard I, Trillet-Lenoir V, Sawyer M, Hanson J, Broussolle C, Negrier S, Dumontet C, Mackey JR: Low serum albumin levels and liver metastases are powerful prognostic markers for survival in patients with carcinoma of unknown primary site. Cancer 2006;107: 2698-2705.
16. Durand JP, Mir O, Coriat R, Cessot A, Pourchet S, Goldwasser F: Validation of the Cochin Risk Index Score (CRIS) for life expectancy prediction in terminally ill cancer patients. Support Care Cancer 2012;20:857-864.
17. Cook MB, McGlynn KA, Devesa SS et al.: Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev 2011;20:1-9.
18. Wolters U, Stutzer H, Isenberg J: Gender related survival in colorectal cancer. Anticancer Res 1996;16A:1281-1289.
19. Hendifar A, Yang D, Lenz F, Lurje G, Pohl A, Lenz C, Ning Y, Zhang W, Lenz HJ: Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res 2009;15:6391-6397.